Thymosin Alpha-1 For Sale — Research Grade
PX1 Research supplies highly purified Thymosin Alpha-1 for laboratory research use only. Our USA-synthesized formulations undergo rigorous HPLC and Mass Spectrometry validation to guarantee exceptional batch consistency for complex in vitro and preclinical signaling studies. Institutional inquiries for bulk allocations and individual research orders are dispatched same-day from our California and Arizona fulfillment centers.
Quick answer
PX1 Research supplies highly purified Thymosin Alpha-1 for laboratory research use only. Our USA-synthesized formulations undergo rigorous HPLC and Mass Spectrometry validation to guarantee exceptional batch consistency for complex in vitro and preclinical signaling studies. Institutional inquiries for bulk allocations and individual research orders are dispatched same-day from our California and Arizona fulfillment centers.
Key takeaways
- [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) (Tα1) is an endogenous 28-amino acid peptide naturally derived from prothymosin alpha, a precursor protein expressed primarily within thymic epithelial cells.
- The primary sequence of [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) is N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, giving it a molecular weight of approximately 3108.3 Da.
- Sourcing high-purity [thymosin alpha-1 for sale](/product/thymosin-alpha-1-5mg) requires strict oversight of solid-phase peptide synthesis (SPPS) protocols.
- Analytical rigor is the cornerstone of empirical science.
Overview of Thymosin Alpha-1 in Laboratory Research
Thymosin Alpha-1 (Tα1) is an endogenous 28-amino acid peptide naturally derived from prothymosin alpha, a precursor protein expressed primarily within thymic epithelial cells. Discovered during biochemical isolations of thymic humoral factors, this acidic peptide plays a fundamental role in modulating early cell-mediated immune dynamics in preclinical models. Laboratory interest in sourcing thymosin alpha-1 for sale stems from its distinct capacity to influence nuclear signaling pathways, dendritic cell maturation, and baseline cytokine output without inducing unspecific cell lysis.
When evaluating candidates for molecular assays, investigators require synthetic peptides manufactured under strict quality standards to eliminate batch-to-batch variance. PX1 Research provides high-grade thymosin alpha-1 5mg vials explicitly formatted for analytical, biochemical, and cell culture applications. Every lot produced for our inventory undergoes exhaustive characterization in an ISO 17025 accredited laboratory, ensuring research institutions receive reliable, non-degraded materials suitable for quantitative downstream assays.
Molecular Structure and Receptor Interaction Pathways
The primary sequence of Thymosin Alpha-1 is N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, giving it a molecular weight of approximately 3108.3 Da. The peptide features a highly acidic amino-terminal region that confers specific binding affinity toward pattern recognition receptors, particularly Toll-like receptor 2 (TLR-2) and Toll-like receptor 9 (TLR-9), in murine and human primary cell lines.
Upon receptor ligation, in vitro assays demonstrate that Tα1 initiates an intracellular cascade via the MyD88-dependent pathway. This signaling axis triggers downstream activation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) cascades. In cultured dendritic cells and macrophage lineages, this mechanism leads to up-regulated expression of major histocompatibility complex class I (MHC-I) molecules and costimulatory markers such as CD80 and CD86. Researchers utilizing our research library hub can access documented studies outlining these exact receptor-ligand kinetics.
Sourcing Criteria for High-Purity Research Compounds
Sourcing high-purity thymosin alpha-1 for sale requires strict oversight of solid-phase peptide synthesis (SPPS) protocols. Because Tα1 contains multiple acidic residues (glutamic and aspartic acid) alongside lysine chains, sub-optimal coupling steps during SPPS can yield truncation sequences or deletion peptides. These structurally incomplete impurities compete with the full-length peptide for receptor binding sites, introducing experimental artifacts and confounding quantitative assay results.
PX1 Research mitigates synthesis errors by employing modern Fmoc chemistry combined with automated microwave-assisted coupling technology. Following cleavage and crude isolation, the compound undergoes preparative reverse-phase high-performance liquid chromatography (RP-HPLC) purification. This exhaustive process removes trifluoroacetate (TFA) salts, residual organic solvents, and truncated fragments, yielding a final product that consistently exceeds 99% chromatographic purity.
Analytical Verification: HPLC, Mass Spectrometry, and COA Standards
Analytical rigor is the cornerstone of empirical science. PX1 Research guarantees that every lot of research-grade peptides is accompanied by a downloadable, lot-specific Certificate of Analysis (COA). We utilize dual testing protocols, combining RP-HPLC to verify chromatographic purity with Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm precise molecular mass.
In addition to structural integrity, research reagents intended for cellular assays must be strictly regulated for biological contaminants. Unbounded bacterial endotoxins (lipopolysaccharides) in peptide preparations can trigger non-specific inflammatory responses in cell culture models, invalidating cytokine production data. PX1 Research enforces stringent Chromogenic LAL (Limulus Amebocyte Lysate) endotoxin testing on all lots, ensuring endotoxin levels remain below strictly defined laboratory limits (typically <0.01 EU/μg).
Comparative Analysis: Immunomodulatory & Signaling Compounds
When designing preclinical assays targeting cellular signaling or tissue maintenance pathways, researchers often evaluate Thymosin Alpha-1 alongside other specialized immunomodulatory and tissue-active peptides. Understanding structural and functional differences allows investigators to select the exact target required for their experimental setup.
While Thymosin Alpha-1 primarily operates via TLR-2/TLR-9 pathways to orchestrate T-cell maturation and dendritic cell signaling, the related thymic fragment Thymosin Beta-4 acts predominantly as an actin-sequestering protein to regulate cell migration and cytoskeletal remodeling. For assays focusing on innate epithelial barrier defense, researchers frequently cross-reference Tα1 with the antimicrobial peptide LL-37, which exerts direct membrane-disrupting capabilities against microbial cell walls. Conversely, studies targeting localized anti-inflammatory signaling cascades often pair or contrast Tα1 with the alpha-MSH derivative KPV tripeptide or the gastroprotective peptide BPC-157.
Preclinical Applications and Cell Culture Investigations
In preclinical animal models and immortalized cell lines, Thymosin Alpha-1 serves as a crucial molecular tool for probing regulatory T-cell (Treg) differentiation and cytotoxic T-lymphocyte (CTL) activation. Literature indicates that in murine splenocyte cultures, exposure to Tα1 elevates the transcription of interleukin-2 (IL-2) and interferon-gamma (IFN-γ) while modulating the expression of anti-inflammatory cytokines like IL-10 depending on the underlying cellular stress state.
Furthermore, in vitro tumor-microenvironment models demonstrate that Tα1 can augment the expression of tumor-associated antigens on target cells, thereby increasing recognition efficiency by effector lymphocytes. Researchers studying viral response mechanisms also utilize Tα1 to investigate intracellular signaling responses to double-stranded RNA analogs in pulmonary epithelial models.
Reconstitution Protocol and In Vitro Storage Requirements
To preserve the structural integrity of the reconstituted peptide during laboratory experiments, precise handling protocols must be observed. Thymosin Alpha-1 is supplied as a lyophilized (freeze-dried) sterile powder sealed under inert gas inside specialized borosilicate glass vials. Lyophilized vials should be stored at -20°C prior to reconstitution to maintain long-term stability.
For laboratory reconstitution, researchers should utilize Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Water for Injection, depending on the requirements of the downstream assay setup. Slowly direct the solvent down the inner glass wall of the vial rather than shooting directly onto the lyophilized cake. Gently swirl the vial until dissolved—never vortex or vigorously shake the peptide solution, as mechanical shear stress can cause polypeptide aggregation. Reconstituted aliquots should be stored at 2°C to 8°C for short-term assays or frozen in single-use aliquots at -80°C to prevent repeated freeze-thaw cycles.
Logistics, Shipping, and Institutional Sourcing Options
Uninterrupted supply chains are vital for maintaining research timelines. PX1 Research operates dual fulfillment hubs in California and Arizona, allowing us to ship orders processed before 3:00 PM EST on the same business day (Monday through Friday). Lyophilized peptides remain highly stable during transit, but expedited options are available for temperature-sensitive reagents.
For university research groups, contract research organizations (CROs), and biotech firms requiring bulk quantities, PX1 offers structured supply agreements through our institutional wholesale account portal. Institutional clients receive direct access to dedicated lot allocations, custom synthesis capabilities, and batch-level COA verification prior to dispatch.
Frequently Asked Questions
What is the purity level of Thymosin Alpha-1 available from PX1 Research?
PX1 Research guarantees a chromatographic purity of ≥99% for every batch of Thymosin Alpha-1. Purity is validated using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
Is a Certificate of Analysis (COA) provided with my order?
Yes. Every lot of Thymosin Alpha-1 shipped by PX1 includes a accessible, lot-specific COA performed by an independent ISO 17025 accredited laboratory detailing RP-HPLC purity, mass identification, and endotoxin levels.
How is Thymosin Alpha-1 packaged and shipped?
Thymosin Alpha-1 is packaged as a lyophilized powder in sterile, sealed glass vials under nitrogen vacuum. Orders placed Monday through Friday before 3:00 PM EST ship same-day from our fulfillment locations in California and Arizona.
What solvent should be used to reconstitute Thymosin Alpha-1 for cell culture use?
For standard laboratory procedures, sterile bacteriostatic water or sterile standard saline (0.9% NaCl) is recommended, depending on whether the downstream assay requires preservative-free buffers.
What are the recommended storage temperatures for lyophilized and reconstituted peptide?
Lyophilized vials should be stored at -20°C for optimal shelf life. Once reconstituted, solutions should be kept at 2°C to 8°C for short-term testing (up to 30 days with bacteriostatic water) or frozen in single-use aliquots at -80°C.
What is the acceptable endotoxin threshold for PX1 Thymosin Alpha-1?
PX1 Research mandates that endotoxin levels remain below 0.01 EU/μg, verified via Chromogenic LAL testing, to prevent non-specific immunogenic activation in sensitive cell culture lines.
How does Thymosin Alpha-1 differ structurally from Thymosin Beta-4?
Thymosin Alpha-1 is an acidic 28-amino acid peptide involved primarily in TLR signaling and T-cell maturation, whereas Thymosin Beta-4 is a 43-amino acid peptide that regulates actin monomer sequestration and cell migration.
Can PX1 accommodate institutional bulk orders for Thymosin Alpha-1?
Yes. We offer bulk pricing, dedicated lot reserves, and custom vial sizes for qualified academic institutions and commercial laboratories through our wholesale account system.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.